Rapid progress in AI research in pathology resulted already in development of accurate tools for Gleason scoring in H&E prostate cancer biopsies [8,9], lymph node metastases recognition in H&E breast cancer specimens [10], assessment of immunohistochemical expression of HER2 in breast cancer [11] and several others [1,6,7]. Here, ERBB2 is linked to breast carcinoma.